Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China.

Techniques in coloproctology·2025
Same author

Search for Sub-GeV Invisible Particles in Inclusive Decays of J/ψ to ϕ.

Physical review letters·2025
Same author

Single Inclusive π^{±} and K^{±} Production in e^{+}e^{-} Annihilation at Center-of-Mass Energies from 2.000 to 3.671 GeV.

Physical review letters·2025
Same author

Precision CP Symmetry Test and Polarization Analysis in Σ^{+} Decays.

Physical review letters·2025
Same author

Precise Measurement of the Form Factors in D^{0}→K^{*}(892)^{-}μ^{+}ν_{μ}, and Test of Lepton Universality with D^{0}→K^{*}(892)^{-}ℓ^{+}ν_{ℓ} Decays.

Physical review letters·2025
Same author

First Measurement of the Decay Dynamics in the Semileptonic Transition of D^{+(0)} into the Axial-Vector Meson K[over ¯]_{1}(1270).

Physical review letters·2025

Related Experiment Video

Updated: Jun 1, 2026

The Fabrication and Operation of a Continuous Flow, Micro-Electroporation System with Permeabilization Detection
10:34

The Fabrication and Operation of a Continuous Flow, Micro-Electroporation System with Permeabilization Detection

Published on: January 7, 2022

Competitive electroporation formulation for cell therapy.

M Flanagan1, J M Gimble, G Yu

  • 1Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, USA.

Cancer Gene Therapy
|June 11, 2011
PubMed
Summary
This summary is machine-generated.

Researchers developed a three-step method to create optimal nucleofection buffers for any cell line. This cost-effective formulation matches or exceeds commercial standards, advancing cell therapy development.

More Related Videos

Microscale Vortex-assisted Electroporator for Sequential Molecular Delivery
10:51

Microscale Vortex-assisted Electroporator for Sequential Molecular Delivery

Published on: August 7, 2014

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring
08:06

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

The Fabrication and Operation of a Continuous Flow, Micro-Electroporation System with Permeabilization Detection
10:34

The Fabrication and Operation of a Continuous Flow, Micro-Electroporation System with Permeabilization Detection

Published on: January 7, 2022

Microscale Vortex-assisted Electroporator for Sequential Molecular Delivery
10:51

Microscale Vortex-assisted Electroporator for Sequential Molecular Delivery

Published on: August 7, 2014

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring
08:06

Porous Substrate-Based Electroporation with Transepithelial Electrical Impedance Monitoring

Published on: September 27, 2024

Area of Science:

  • Biotechnology
  • Cell Biology
  • Molecular Biology

Background:

  • Nucleofection is an effective cell transfection method, but proprietary buffer compositions hinder its use in cell therapy development.
  • Trade secrecy surrounding commercial nucleofection buffers limits research and optimization efforts.

Purpose of the Study:

  • To devise a systematic method for discovering optimal nucleofection buffer formulations for diverse cell lines.
  • To develop cost-effective nucleofection solutions that match or surpass commercial standards for cell therapy applications.

Main Methods:

  • A three-step selection process was employed: optimizing nucleofection programs and buffer types, identifying effective polymers, and comparing against a commercial standard (Amaxa).
  • Scanning electron microscopy was used to investigate morphological changes facilitating nuclear DNA transfer.

Main Results:

  • Novel nucleofection formulations were identified that are equally or more efficient than commercial solutions across various cell types, including primary adipose stem cells, muscle cells, tumor cells, and immune cells.
  • Morphological changes induced by the new buffers were visualized, correlating with enhanced DNA transfer efficiency.

Conclusions:

  • The developed three-step method successfully identified competitive nucleofection formulations for broad cell line applicability.
  • These findings offer a potential to significantly reduce the cost of electroporation studies and accelerate the clinical application of cell-based therapies.